Lonza has been a dominant player in contract development and manufacturing for decades. We think its outlook is bright, especially as drug manufacturing becomes more complex, with biologics and cell ...

The global Empty Capsules Market, valued at US$3.05 billion in 2024, stood at US$3.19 billion in 2025 and is projected to advance at a resilient CAGR of 5.6% from 2025 to 2030, culminating in a ...